TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Improvement in communication skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased client satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decreased risk of cancer
Endpoint domain: Mortality/survival
Primary endpoint: fecal bulk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fecal butyrate:SCFA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Swollen and tender joint count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Residual marker amount in colonic transit test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Scores of SAS and SDS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Collagen remodeling in the dermis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum levels of oxLDL/beta2GPI complexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Throwing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autonomous motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of crossover tasks passed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of intracorporeal knot tying tasks passed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAM-A psychic subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall improvement in knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: decrease in casual blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increase in renal perfusion (RPF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Adequacy of endoscopic grasp biopsies for small intestinal histology assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CVA Index (CVAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean reduction in AK count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermatology Life Quality Index (DLQI) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 60% decrease in the frequency of binge eating or vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: efficiency of chest compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttransfusion CCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent breast density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ETT cuff pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained VR control (<90 bpm) within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: H pylori eradication success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heat pain tolerance thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rcq‐36 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Congestion symptom score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid blood spectrum improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prooxidant-antioxidant status improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Elevation in Free‐Car concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in proportions of monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dynamic muscle pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: summed difference score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Induction of clinical remission (CAI < or = 3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of MR imaging for medial meniscal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of MR imaging for lateral meniscal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of MR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious medical events
Endpoint domain: Mortality/survival
Primary endpoint: Stigmatization for body weight
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Survival (OS) prolongation
Endpoint domain: Mortality/survival
Primary endpoint: Rectus abdominis muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Chest muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: global grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment motivation and engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visceral perception to rectal distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local-regional control
Endpoint domain: Mortality/survival
Primary endpoint: Symptom management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Types of death
Endpoint domain: Mortality/survival
Primary endpoint: Postquestionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: inflammatory gene expression in SAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of primary indoor falls needing GP intervention or emergency room attendance
Endpoint domain: Adverse events/effects
Primary endpoint: changes in FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: nighttime awakenings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: blood eosinophil counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: QOLRAD scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in SUV values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized mean height velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF‐1 standard deviation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: insulin resistance prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resolution of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HDL2 cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IGA score of 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100% lesion reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RITA-T score for identifying ASD risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uNTx/creatinine reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SRE occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Functional outcome as assessed by NIHSSS after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular itching score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in prostate volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: Peak urinary flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: Postvoid residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urological outcomes
Primary endpoint: Preference for comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Activated CECs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survivin mRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of Malassezia growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 5-year risk of stroke and death
Endpoint domain: Mortality/survival
Primary endpoint: CSF levels of serotonin and related metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in the area of enamel opacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with dental appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: fatigue characteristics
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Adrenal suppression
Endpoint domain: Adverse events/effects
Primary endpoint: Severity and extent of Atopic Dermatitis (AD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: reading comprehension
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EO and IO thickness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reestablishment of peristaltism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: average total admission fee
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: average antibiotic fee
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of injected vials of antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Opioid consumption in hospital
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Daily pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjunct opioid consumption for 1 week after discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: carer burden
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Side-to-side difference (SSD) for lateral compartment laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective outcome scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: presence of MVO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of CV mortality, myocardial infarction, or ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Plasma NT-proBNP concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preference for tadalafil over sildenafil
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: risk of death within three years after primary angioplasty
Endpoint domain: Mortality/survival
Primary endpoint: costs after three years of follow-up
Endpoint domain: Resource use
Primary endpoint: Patient-Reported Outcomes (PROs)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: strict remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28 AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total performance times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Grade 3/4 neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of informed choice about DSS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of high grade squamous intraepithelial lesions (HSIL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity for detection of cervical intraepithelial neoplasia (grades 1-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity for detection of cervical intraepithelial neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean level of gastric pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: adherence to a healthy diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of disability (modified Rankin scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of functional independence (score of 0 to 2)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: LDL values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum T3, FT3, and T4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: number of patients requiring inotropic drugs in the ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: myocardial expression of HSP70 and MHCα mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Light intensity activity increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vegetable intake increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician judgment of treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RAD-relevant WST scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of early glaucomatous defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Interference with daily function
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction of IL-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of IL-1β levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of MCP-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in mSASSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of portal-systemic encephalopathy (PSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Distal radius volumetric BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of morphine administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of overt DM and consequent death
Endpoint domain: Mortality/survival
Primary endpoint: MIS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LBM change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher numbers of SELs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Higher T2 volumes of SELs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Decrease in T1 intensity over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Median Visual Analog Scale (VAS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time for the demand of the first analgesic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: improvements in visual and verbal memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy of working dies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort ranking of impression trays
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy of treatment strategies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Higher odds of healthy aging (HA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vestibular-ocular reflex gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cured and markedly effective rate of TCM symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate for TCM symptoms of fever and headache
Endpoint domain: Adverse events/effects
Primary endpoint: Mean CDRS‐R score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent-reported fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: child-reported fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Composite all-cause death/MI
Endpoint domain: Mortality/survival
Primary endpoint: Acceptability of CRP point-of-care testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Negative mycological culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proximal nail plate clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA decline >= 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to PSA progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood glucose levels after 4 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: visual acuity ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: facial lines and wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: cutaneous collagen content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Intention to reduce drinking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Personal goals related to drinking
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Engagement with intervention components
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Blood Volume (BV) status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RVEDVI levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean annual growth rate of small AAAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of being referred for surgical evaluation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of change from baseline in forced expiratory volume in 1 second (FEV(1))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total liver fat volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Successful outcome (Responders)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DWI T2 shine-through effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discs' shrinkage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Locoregional control (LRC) at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQOL impairment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Volume of leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motion sickness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Otolith-ocular reflex sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in state anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower level of myocardial oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lower level of respiration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ongoing pregnancy rate
Endpoint domain: Mortality/survival
Primary endpoint: coital injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scratches/abrasions/cuts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of benzydamine
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate at 12-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean differences in MADRS score at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes